Medications currently used to treat multiple sclerosis (MS) can merely reduce relapses during the initial relapsing-remitting phase. Many patients, however, develop progressive MS at a later stage, with disability becoming ...
Aug 20, 2019
0
4
(HealthDay)—The target trough concentration of vancomycin seems to be lower for adolescents than for adults, according to a study published online June 13 in the Journal of Clinical Pharmacology.
Jun 17, 2016
0
10
Researchers have found that severe malnutrition is associated with lower exposure to the antimalarial drug lumefantrine in children treated with artemether-lumefantrine, the most common treatment, for uncomplicated falciparum ...
Jul 24, 2019
0
0
